Technologies under development:
Mesenchymal stem cell transplantation and repair of degenerative knee diseases;
Mesenchymal stem cell transplantation for treatment of premature ovarian failure;
Gene therapy for thalassemia;
IPSC directional induction and differentiation technique;

New biomaterials as scaffolds for mesenchymal stem cell transplantation;
Mature technology:NK, CIK and other techniques for isolation and culture of immune cells;

Isolation and culture of umbilical cord-derived mesenchymal stem cells;

Isolation and culture of bone marrow derived mesenchymal stem cells;

Isolation and culture of adipose derived mesenchymal stem cells;

Isolation and culture of umbilical cord blood derived mesenchymal stem cells;

Patent Technology:


A method for the separation of hematopoietic stem cells from human peripheral blood;


Rapid enrichment and separation of natural killer cells in human peripheral blood;


A method to improve the ability of human mesenchymal stem cells to osteoblast differentiation;


A natural killer T cell activator peptide and its application;


The invention relates to a preparation method of tissue engineering cell culture scaffold;


A method for preparing mesenchymal stem cells by cell factory;